A study of Neuroligin-3 (NL3) mutated mice, who exhibit autism spectrum disorder symptoms, led to the discovery that the D1 MSNs in the NAc show reduced synaptic inhibition compared to excitation (Rothwell et al., 2014). This evidence concerns the gene NLGN3 and autism spectrum disorder.